Leiden, The Netherlands, September 19, 2007. Biotech company Pharming Group NV (“Pharming”) (Euronext: PHARM) today announced that the Dutch government will provide funding of EUR 45 million to the BioMedical Materials program (BMM), as was announced yesterday during the presentation of the national budget for 2008.
